TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 1 | 0 | 13 | 16 | 41 | 115 | 31 |
| P | %wins | 75 | 75 | 50 | 50 | 50 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/5/20 17:04 | 6/3/20 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Young James F | MD | D | P | 73 | 48.83 | 0 | 2 | New | 2 | I | |||||||||||||||
3/25/14 17:48 | 3/25/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Young James F | MD | D | P | 112 | 4.47 | 33 | 25 | 6 | 425 | D | 215 | 91 | 32 | -12 | -29 | -35 | -24 | -20 | -2 | 1 | -7 | 10 | -4 | 116 | |
6/10/13 09:03 | 6/6/13 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Young James F | MD | D | P | 191 | 1.91 | 3 | 100 | 33 | 400 | D | -13 | 53 | 3 | -8 | -24 | -6 | -6 | 5 | 3 | 1 | 36 | 72 | 115 | 133 | |
3/12/13 13:45 | 3/11/13 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Young James F | MD | D | P | 203 | 2.03 | 1 | 100 | 50 | 300 | D | -20 | 63 | 4 | 15 | 14 | 8 | 13 | 12 | 0 | 3 | 31 | -6 | 63 | 186 | |
12/6/11 09:36 | 12/1/11 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Young James F | MD | D | P | 292 | 1.46 | 1 | 200 | 83 | 440 | D | -55 | -35 | -33 | -17 | -13 | -1 | 17 | 6 | 3 | -4 | -8 | -14 | -12 | 23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |